IDX Stock Overview
A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Integral Diagnostics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$3.00 |
| 52 Week High | AU$3.20 |
| 52 Week Low | AU$1.80 |
| Beta | 0.68 |
| 1 Month Change | 1.35% |
| 3 Month Change | 14.50% |
| 1 Year Change | 57.07% |
| 3 Year Change | -39.15% |
| 5 Year Change | -22.08% |
| Change since IPO | 63.93% |
Recent News & Updates
Recent updates
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital
Feb 21
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being
Nov 22Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year
Feb 20These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively
Dec 14Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?
May 26Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year
Feb 28Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate
Feb 25Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why
Oct 29Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?
Sep 13An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued
Jun 04Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?
May 14Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?
May 03We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt
Apr 16Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Mar 27Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?
Mar 17The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About
Mar 07Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend
Feb 25Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?
Feb 23Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?
Feb 13Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price
Feb 03
Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)
Jan 24Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?
Jan 14Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return
Jan 05Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Dec 26At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?
Dec 17What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend
Dec 08Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture
Nov 29Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?
Nov 19Shareholder Returns
| IDX | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | -1.0% | -3.1% | -2.0% |
| 1Y | 57.1% | -6.6% | 7.8% |
Return vs Industry: IDX exceeded the Australian Healthcare industry which returned -6.6% over the past year.
Return vs Market: IDX exceeded the Australian Market which returned 7.8% over the past year.
Price Volatility
| IDX volatility | |
|---|---|
| IDX Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.8% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: IDX has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: IDX's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 1,977 | Ian Kadish | www.integraldiagnostics.com.au |
Integral Diagnostics Limited, a healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides positron emission tomography, magnetic resonance imaging, and other radiology services. The company was founded in 1967 and is headquartered in Melbourne, Australia.
Integral Diagnostics Limited Fundamentals Summary
| IDX fundamental statistics | |
|---|---|
| Market cap | AU$701.75m |
| Earnings (TTM) | -AU$60.70m |
| Revenue (TTM) | AU$469.70m |
1.5x
P/S Ratio-11.6x
P/E RatioIs IDX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IDX income statement (TTM) | |
|---|---|
| Revenue | AU$469.70m |
| Cost of Revenue | AU$317.80m |
| Gross Profit | AU$151.90m |
| Other Expenses | AU$212.60m |
| Earnings | -AU$60.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 25, 2025
| Earnings per share (EPS) | -0.26 |
| Gross Margin | 32.34% |
| Net Profit Margin | -12.92% |
| Debt/Equity Ratio | 72.8% |
How did IDX perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield-22%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 18:37 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Integral Diagnostics Limited is covered by 24 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Thomas Yeo | Barrenjoey Markets Pty Limited |
| Saul Hadassin | Barrenjoey Markets Pty Limited |